Risk for adverse health outcome in antipsychotic-naive adolescents after 12 months of treatment with second-generation antipsychotics

L. Pina-Camacho, J. Merchan-Naranjo, M. Garcia-Amador, D. Fraguas, C. Tapia, C. Moreno, C. Llorente, C. Arango

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Pages (from-to)	S61-S62
Journal	European Neuropsychopharmacology
Volume	21
Publication status	Published - Mar 2011

Cite this

@article{45b380402c4f47c481caba3b0c263ab3,

title = "Risk for adverse health outcome in antipsychotic-naive adolescents after 12 months of treatment with second-generation antipsychotics",

author = "L. Pina-Camacho and J. Merchan-Naranjo and M. Garcia-Amador and D. Fraguas and C. Tapia and C. Moreno and C. Llorente and C. Arango",

year = "2011",

month = mar,

language = "English",

volume = "21",

pages = "S61--S62",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier",

}

TY - JOUR

T1 - Risk for adverse health outcome in antipsychotic-naive adolescents after 12 months of treatment with second-generation antipsychotics

AU - Pina-Camacho, L.

AU - Merchan-Naranjo, J.

AU - Garcia-Amador, M.

AU - Fraguas, D.

AU - Tapia, C.

AU - Moreno, C.

AU - Llorente, C.

AU - Arango, C.

PY - 2011/3

Y1 - 2011/3

M3 - Meeting abstract

SN - 0924-977X

VL - 21

SP - S61-S62

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

ER -